70594-023Level 3
Colistimethate (colistimethate sodium)
**Product type:** Human Prescription Drug
**Active ingredient:** COLISTIMETHATE SODIUM
**Strength:** 150 mg/1
**Dosage form:** Injection, Powder, For Solution
**Route:** Intramuscular; Intravenous
**Labeler:** Xellia Pharmaceuticals USA LLC
**Marketing category:** ANDA (ANDA205356)
**Pharmacologic class:** Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
GET
/api/v1/systems/ndc_fda/nodes/70594-023Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.